Nashat Gabrail
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers 19
- Cancer Treatment and Pharmacology 14
- Colorectal Cancer Treatments and Studies 11
- CAR-T cell therapy research 11
- Hematology top 1%
- Multiple Myeloma Research and Treatments 26
- Cancer Research top 2%
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research 10
-
- Protein Degradation and Inhibitors 20
-
- Lung Cancer Treatments and Mutations 17
- Co-authors
- Nicholas IannottiEdith P. MitchellMichael Craig MillerSteven J. CohenBruce SaidmanCornelis J.A. PuntNeal J. MeropolKert D. Sabbath
- Cited by
- OncologyHematologyCancer Research
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Nashat Gabrail
145 papers receiving 4.3k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Oncology 2.3k
- Hematology 828
- Cancer Research 1.1k
- Genetics 394
- Anesthesiology and Pain Medicine 142
Countries citing papers authored by Nashat Gabrail
This map shows the geographic impact of Nashat Gabrail's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nashat Gabrail with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nashat Gabrail more than expected).
Fields of papers citing papers by Nashat Gabrail
This network shows the impact of papers produced by Nashat Gabrail. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nashat Gabrail. The network helps show where Nashat Gabrail may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nashat Gabrail, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 5 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 11 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 0 | |
| 10 | 2023 | 2 | |
| 11 | 2019 | 14 | |
| 12 | 2018 | 38 | |
| 13 | 2018 | 1 | |
| 14 | 2017 | 112 | |
| 15 | 2014 | 33 | |
| 16 | 2013 | 169 | |
| 17 | 2011 | 26 | |
| 18 | 2010 | 68 | |
| 19 | Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal Cancerbreakdown → | 2008 | 1473 |
| 20 | 2007 | 1 |
About Nashat Gabrail
Nashat Gabrail is a scholar working on Hematology, Oncology and Genetics, having authored 154 papers that have together received 4.4k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (26 papers), Protein Degradation and Inhibitors (20 papers), Cancer Immunotherapy and Biomarkers (19 papers), Lung Cancer Treatments and Mutations (17 papers), Cancer Treatment and Pharmacology (14 papers), Colorectal Cancer Treatments and Studies (11 papers), CAR-T cell therapy research (11 papers) and Chronic Lymphocytic Leukemia Research (10 papers). The work is most often cited by research in Oncology (2.3k citations), Hematology (828 citations) and Cancer Research (1.1k citations). Nashat Gabrail has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Nicholas Iannotti, Edith P. Mitchell, Michael Craig Miller, Steven J. Cohen, Bruce Saidman, Cornelis J.A. Punt, Neal J. Meropol, Kert D. Sabbath, Joel Picus and Gerald V. Doyle. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.